Tardive Dyskinesia Has Considerable Impact on Multiple Domains
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
TUESDAY, Aug. 22, 2023 -- Tardive dyskinesia (TD) has a considerable impact on physical, psychological, social, and professional lives, according to a study published in the May/June issue of the Journal of Clinical Psychiatry.
Rakesh Jain, M.D., M.P.H., from Texas Tech University School of Medicine-Permian Basin in Midland, and colleagues examined the patient burden of TD using an online survey developed through a targeted literature review and interviews with clinicians, patients, and caregivers. Adult survey participants with current diagnoses of TD and schizophrenia, bipolar disorder, or major depressive disorder rated the impact of TD on their physical, psychological, and social functioning on Likert scales scored from 1 to 5. A total of 269 patients responded to the survey.
The researchers found that the mean impact scores reported in the physical, psychological, and social domains were 3.1, 3.5, and 3.2, respectively; scores increased with reported severity of TD symptoms. For all domains, patients with underlying schizophrenia reported the highest burden. Activity impairment of 66.2 percent was reported by patients because of TD. Of the 193 employed patients, 29.1, 68.4, and 73.5 percent reported absenteeism, presenteeism, and overall work impairment, respectively. Due to TD, 48.4 and 39.3 percent of patients reported skipping/reducing or stopping their antipsychotic medication and 35.7 percent reported stopping visits to clinicians treating their underlying condition.
"These results reinforce the need for health care providers to assess multiple domains of impact when assessing TD movements," the authors write.
Several authors disclosed ties to the pharmaceutical industry, including Teva Branded Pharmaceutical Products R&D Inc., which funded the trial.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted August 2023
Read this next
Positive Psychology Intervention Aids Allogeneic Stem Cell Transplant Survivors
THURSDAY, June 13, 2024 -- A telephone-delivered positive psychology intervention (Positive Affect for the Transplantation of Hematopoietic stem cells intervention [PATH]) is...
New Neurocognitive/Functional Morbidity Explored in SARS-CoV-2, MIS-C
WEDNESDAY, June 12, 2024 -- Children with acute severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and multisystem inflammatory syndrome in children (MIS-C) with severe...
Smoking Cessation Aids Equally Effective in Those With Mental Health Conditions
THURSDAY, June 6, 2024 -- Popular smoking cessation aids are equally effective in those with or without a history of mental health conditions, according to a study published...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.